Cascadian Therapeutics to Participate in Panel Discussions at Two Conferences in November
October 24, 2017 08:05 ET
|
Cascadian Therapeutics, Inc.
SEATTLE, Oct. 24, 2017 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced that Scott D. Myers, President and Chief Executive...